SG11202006669RA - Peptides and uses thereof - Google Patents

Peptides and uses thereof

Info

Publication number
SG11202006669RA
SG11202006669RA SG11202006669RA SG11202006669RA SG11202006669RA SG 11202006669R A SG11202006669R A SG 11202006669RA SG 11202006669R A SG11202006669R A SG 11202006669RA SG 11202006669R A SG11202006669R A SG 11202006669RA SG 11202006669R A SG11202006669R A SG 11202006669RA
Authority
SG
Singapore
Prior art keywords
peptides
Prior art date
Application number
SG11202006669RA
Other languages
English (en)
Inventor
Andrew Gearing
David Kenley
Original Assignee
Lateral IP Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018900117A external-priority patent/AU2018900117A0/en
Application filed by Lateral IP Pty Ltd filed Critical Lateral IP Pty Ltd
Publication of SG11202006669RA publication Critical patent/SG11202006669RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11202006669RA 2018-01-15 2019-01-15 Peptides and uses thereof SG11202006669RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018900117A AU2018900117A0 (en) 2018-01-15 Peptides and uses thereof
PCT/AU2019/050020 WO2019136528A1 (en) 2018-01-15 2019-01-15 Peptides and uses thereof

Publications (1)

Publication Number Publication Date
SG11202006669RA true SG11202006669RA (en) 2020-08-28

Family

ID=67218208

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006669RA SG11202006669RA (en) 2018-01-15 2019-01-15 Peptides and uses thereof

Country Status (11)

Country Link
US (1) US20200390850A1 (ko)
EP (1) EP3740228A4 (ko)
JP (1) JP7282099B2 (ko)
KR (1) KR20200130681A (ko)
CN (1) CN112218650A (ko)
AU (1) AU2019207531B2 (ko)
BR (1) BR112020014330A2 (ko)
CA (1) CA3088014A1 (ko)
RU (1) RU2020123165A (ko)
SG (1) SG11202006669RA (ko)
WO (1) WO2019136528A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206368A (zh) * 2019-05-31 2022-03-18 横向知识产权私人有限公司 肽及其用途
AU2020364246A1 (en) * 2019-10-10 2022-05-12 The Research Foundation For The State University Of New York Analgesic and anesthetic peptides and other agents
EP4081237A4 (en) * 2019-12-27 2024-01-17 Lateral IP Pty Ltd CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-TYPE PROTEIN (LANCL) AND USES THEREOF
AU2021237981A1 (en) * 2020-03-16 2022-10-13 Lateral IP Pty Ltd Compositions for treating respiratory tract infection and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9811755A (pt) 1997-09-08 2000-08-29 Metabolic Pharmaceutical Ltd Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
EP1395279B1 (en) * 2001-03-28 2011-10-05 Biogen Idec MA Inc. Use of neublastin polypeptides for treating neuropathic pain
US20040077543A1 (en) * 2001-03-28 2004-04-22 Sah Dinah W. Y. Treatment using neublastin polypeptides
WO2003092725A1 (en) * 2002-05-03 2003-11-13 Metabolic Pharmaceuticals Limited Method for control of depression using c terminal growth hormone (gh) fragment
EP2152726B8 (en) * 2007-05-01 2015-02-18 Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP Analgesic compounds
ES2764106T3 (es) 2011-12-09 2020-06-02 Metabolic Pharmaceuticals Pty Ltd Uso de fragmentos de la hormona del crecimiento
US10155026B2 (en) * 2015-12-03 2018-12-18 Children's Hospital Medical Center Methods for treating pain caused by inflammation induced mechanical and/or thermal hypersensitivity

Also Published As

Publication number Publication date
AU2019207531A1 (en) 2020-07-30
EP3740228A1 (en) 2020-11-25
US20200390850A1 (en) 2020-12-17
CA3088014A1 (en) 2019-07-18
JP7282099B2 (ja) 2023-05-26
AU2019207531B2 (en) 2022-06-02
KR20200130681A (ko) 2020-11-19
BR112020014330A2 (pt) 2020-12-08
RU2020123165A (ru) 2022-02-17
JP2021510731A (ja) 2021-04-30
WO2019136528A1 (en) 2019-07-18
CN112218650A (zh) 2021-01-12
EP3740228A4 (en) 2021-12-15

Similar Documents

Publication Publication Date Title
EP4076448A4 (en) FLUOROALKYLATED OXADIAZOLES AND THEIR USES
IL268593A (en) Polypeptide variants and uses thereof
IL287781A (en) Clec-12a binding polypeptides and uses thereof
IL290414A (en) atf5 peptide variants and uses thereof
IL280808A (en) OX40-binding polypeptides and their uses
SG11202006669RA (en) Peptides and uses thereof
IL287782A (en) 33cd-binding polypeptides and their uses
GB201819200D0 (en) Polypeptide and uses thereof
EP3882263A4 (en) GLUCAGON DERIVED PEPTIDE AND USE THEREOF
GB201817821D0 (en) TCR and peptides
EP3480212C0 (en) IL13RALPHA2 PEPTIDE AND ITS USES
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
EP3611181A4 (en) ATP1A1T TARGETING POLYPEPTIDE AND USES
IL284006A (en) Mitochondria-targeted peptides
IL280450A (en) A peptide derived from cdca1 and a preparation containing it
IL280369A (en) New myokines and uses thereof
GB2582571B (en) Peptides and use thereof
EP3976630A4 (en) ACTRII-BINDING PROTEINS AND THEIR USES
SG11202007887VA (en) Cyclic peptides and uses thereof
HUP1700012A2 (en) Novel proteins and use thereof
IL284666A (en) New peptides and their uses
GB201812328D0 (en) Polypeptides and uses thereof
IL287503A (en) Thio-semicarbazide compounds and their use
AU2018900117A0 (en) Peptides and uses thereof